AbbVie’s Humira was the top-selling drug in the world for many years. Now, its sales are eroding as doctors switch to ...

Despite the approval, US patients must wait until the US patent on Humira expires on September 30, 2023, at which time Hyrimoz can be legally prescribed. Meanwhile, the EU patent for AbbVie’s ...

Zoom in: In April, Sandoz's biosimilar known as Hyrimoz contributed to roughly 93% of all new prescriptions of Humira biosimilars. CVS' Cordavis unit began to co-brand Hyrimoz with Sandoz earlier ...

EMA advisors at the Committee for Medicinal Products for Human Use (CHMP) recommended Sandoz’s adalimumab Humira biosimilar under three brand names – Halimatoz, Hefiya and Hyrimoz. The firm ...

Hyrimoz is a biosimilar, a biologic copy of Humira. It's one of several that launched last year in the U.S. New prescriptions of Hyrimoz climbed 3% in the last week of March. In the weeks ended ...

Swiss drugmaker Sandoz also said on Saturday that it had launched a Humira biosimilar, Hyrimoz, at a 5% discount to the branded medicine’s price, as well as an unbranded version of Humira at an ...